XML Print


Department of Sports Physiology, Isf.C., Islamic Azad University, Isfahan, Iran
Abstract:   (12 Views)
Introduction: Type 2 diabetes is one of the most common chronic metabolic diseases and is associated with increased inflammatory markers. The present study aimed to investigate the effect of moderate-intensity aerobic exercise on interleukin (IL)-8, IL-1β, and nuclear factor kappa B (NFκB) levels in women with type 2 diabetes.
Materials and Methods: This semi-experimental study employed a pretest-posttest design with a control group. Thirty women aged 40 to 50 years with at least three years of diagnosed type 2 diabetes were purposefully selected and randomly assigned to either an exercise group or a control group (n = 15 per group). The exercise group participated in an 8-week progressive aerobic training program (three sessions per week) at 35-75% of maximum heart rate. IL-8 and IL-1β levels were measured using the enzyme-linked immunosorbent assay method, and NFκB activity was assessed through western blot analysis from blood serum samples.
Results: The findings indicated a significant decrease in IL-8 and IL-1β levels, and in NFκB activity, in the exercise group compared to the control group after the intervention (p < 0.001). This reduction was statistically significant both within the exercise group compared to the pretest and compared with the control group.
Conclusion: This study demonstrates that moderate-intensity aerobic exercise significantly reduces inflammatory markers in women with type 2 diabetes. It appears that aerobic exercise may be recommended as an effective non-pharmacological approach to improve inflammatory status and assist in the management of type 2 diabetes.
Full-Text [PDF 257 kb]   (6 Downloads)    
Type of Study: Research | Subject: Biochemistry
Received: 2025/10/11 | Accepted: 2025/12/20

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2026 CC BY-NC 4.0 | International Journal of Medical Laboratory

Designed & Developed by : Yektaweb